The advent of Medicare Part D helped move the nation toward the "critically important" goal of lipid control, with more people using cholesterol-lowering drugs after 2006 than before. However, racial gaps in statin use persist, suggesting factors besides drug coverage are fueling the disparity. After Part D was introduced, the number of heart disease or diabetes patients taking the drugs rose, with 48% of black patients and 65% of white patients taking statins. Differences in care quality, patient preferences and health status may contribute to the disparity, lead researcher Joseph Hanlon said in the American Heart Journal study.
Published in Brief: